Close Menu

NEW YORK – The US Food and Drug Administration has revoked its Emergency Use Authorization for Autobio Diagnostics' Anti-SARS-CoV-2 Rapid Tests for IgM and IgG antibodies due to concerns about its accuracy, the agency said on Friday.

The test can no longer be distributed in the US.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.